buthionine sulfoximine glutathione The synthesis inhibitor synergistically enhanced melphalan activity against preclinical models of multiple myeloma Shown to improve the outcome of chemotherapy by lowering the levels of glutathione in cancer cells (IC50 = 1.9 Proxidant Injection Causes the Onset
Description
doi: 10.1111/j.2042-7158.1997.tb06822.x
The peptide has been investigated for applications in coronary artery disease research, heart failure mechanisms, and post-heart attack recovery optimization strategies
Its a well-documented phenomenon
182 SchaferF
[121] After the IF/B 12 complex binds to cubam the complex is disassociated and the free vitamin is transported into the portal circulation
doi:10.3389/fpubh.2021.695139 45
